Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
P. Massion (Tennessee, United States of America). Genome-wide approaches to lung cancer. Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease

Member's Comments

No comment yet.

Related content which might interest you: Which gene expression signatures in pharmacogenomic strategies for lung cancer? Source: Annual Congress 2010 - Customised chemotherapy for lung cancer Year: 2010 Breath biomarkers of lung cancer and other diseases Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease Year: 2010 Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Lung cancer Source: Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension Year: 2010 Biomarkers for lung cancer screening Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Improvements in lung cancer surgery Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results Year: 2011 SHOX2 DNA methylation is a promising biomarker for the diagnosis of lung cancer in plasma Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 In silico gene expression analysis of small cell lung cancer Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Gene expression profiles predict survival of patients with advanced non-small cell lung cancers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 IPF and lung cancer: what are the links? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Genetic predisposition to nonsmall-cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001 Metabolomics in lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Molecular signatures of exposure and subtype in lung cancer tissue from uranium miners Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Multi-omic molecular profiling of lung cancer in COPD Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017 Year: 2018 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015